ABEO
Price
$5.43
Change
+$0.07 (+1.31%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
278.96M
51 days until earnings call
CRNX
Price
$45.91
Change
+$10.02 (+27.92%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
4.32B
40 days until earnings call
Interact to see
Advertisement

ABEO vs CRNX

Header iconABEO vs CRNX Comparison
Open Charts ABEO vs CRNXBanner chart's image
Abeona Therapeutics
Price$5.43
Change+$0.07 (+1.31%)
Volume$21.74K
Capitalization278.96M
Crinetics Pharmaceuticals
Price$45.91
Change+$10.02 (+27.92%)
Volume$55.88K
Capitalization4.32B
ABEO vs CRNX Comparison Chart in %
Loading...
ABEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABEO vs. CRNX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABEO is a Buy and CRNX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (ABEO: $5.43 vs. CRNX: $45.91)
Brand notoriety: ABEO and CRNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABEO: 69% vs. CRNX: 496%
Market capitalization -- ABEO: $274.85M vs. CRNX: $3.38B
ABEO [@Biotechnology] is valued at $274.85M. CRNX’s [@Biotechnology] market capitalization is $3.38B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABEO’s FA Score shows that 1 FA rating(s) are green whileCRNX’s FA Score has 0 green FA rating(s).

  • ABEO’s FA Score: 1 green, 4 red.
  • CRNX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ABEO and CRNX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABEO’s TA Score shows that 4 TA indicator(s) are bullish while CRNX’s TA Score has 5 bullish TA indicator(s).

  • ABEO’s TA Score: 4 bullish, 6 bearish.
  • CRNX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CRNX is a better buy in the short-term than ABEO.

Price Growth

ABEO (@Biotechnology) experienced а +0.93% price change this week, while CRNX (@Biotechnology) price change was +35.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Reported Earning Dates

ABEO is expected to report earnings on Nov 17, 2025.

CRNX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($4.32B) has a higher market cap than ABEO($279M). ABEO YTD gains are higher at: -2.513 vs. CRNX (-10.209). ABEO has higher annual earnings (EBITDA): 80M vs. CRNX (-419.62M). CRNX has more cash in the bank: 1.2B vs. ABEO (226M). ABEO has less debt than CRNX: ABEO (24.1M) vs CRNX (49.9M). CRNX has higher revenues than ABEO: CRNX (1.39M) vs ABEO (400K).
ABEOCRNXABEO / CRNX
Capitalization279M4.32B6%
EBITDA80M-419.62M-19%
Gain YTD-2.513-10.20925%
P/E Ratio8.50N/A-
Revenue400K1.39M29%
Total Cash226M1.2B19%
Total Debt24.1M49.9M48%
FUNDAMENTALS RATINGS
ABEO vs CRNX: Fundamental Ratings
ABEO
CRNX
OUTLOOK RATING
1..100
5810
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
89
Overvalued
PROFIT vs RISK RATING
1..100
10061
SMR RATING
1..100
2097
PRICE GROWTH RATING
1..100
6449
P/E GROWTH RATING
1..100
78100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABEO's Valuation (76) in the Pharmaceuticals Generic industry is in the same range as CRNX (89) in the Pharmaceuticals Major industry. This means that ABEO’s stock grew similarly to CRNX’s over the last 12 months.

CRNX's Profit vs Risk Rating (61) in the Pharmaceuticals Major industry is somewhat better than the same rating for ABEO (100) in the Pharmaceuticals Generic industry. This means that CRNX’s stock grew somewhat faster than ABEO’s over the last 12 months.

ABEO's SMR Rating (20) in the Pharmaceuticals Generic industry is significantly better than the same rating for CRNX (97) in the Pharmaceuticals Major industry. This means that ABEO’s stock grew significantly faster than CRNX’s over the last 12 months.

CRNX's Price Growth Rating (49) in the Pharmaceuticals Major industry is in the same range as ABEO (64) in the Pharmaceuticals Generic industry. This means that CRNX’s stock grew similarly to ABEO’s over the last 12 months.

ABEO's P/E Growth Rating (78) in the Pharmaceuticals Generic industry is in the same range as CRNX (100) in the Pharmaceuticals Major industry. This means that ABEO’s stock grew similarly to CRNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABEOCRNX
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 9 days ago
76%
Declines
ODDS (%)
Bearish Trend 10 days ago
87%
Bearish Trend 5 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ABEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACGYF21.07N/A
N/A
Subsea 7 S.A.
LZAGY64.99N/A
N/A
Lonza Group AG
URLOF1.05N/A
N/A
NameSilo Technologies Corp.
MAOFF1.61N/A
N/A
MAOYAN ENTMT
URZEF0.20N/A
N/A
URZ3 ENERGY CORP.

ABEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABEO has been loosely correlated with ZYME. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ABEO jumps, then ZYME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABEO
1D Price
Change %
ABEO100%
+1.31%
ZYME - ABEO
47%
Loosely correlated
+2.60%
ELVN - ABEO
45%
Loosely correlated
+7.65%
OCUL - ABEO
43%
Loosely correlated
+2.33%
DYN - ABEO
42%
Loosely correlated
+4.53%
CRNX - ABEO
42%
Loosely correlated
+27.92%
More

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
+27.92%
XNCR - CRNX
62%
Loosely correlated
+12.00%
NUVL - CRNX
57%
Loosely correlated
+4.99%
DYN - CRNX
57%
Loosely correlated
+4.53%
IDYA - CRNX
56%
Loosely correlated
+4.52%
VRDN - CRNX
55%
Loosely correlated
+5.77%
More